CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us
  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Microgravity R&D
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
Top Drug Discovery and Development Companies in Europe Top Drug Discovery and Development Solutions Companies in Europe - 2023 Top Small Molecules Drug Discovery and Development Solutions Companies in Europe - 2022 Top Drug Discovery and Development Solution Companies in Europe - 2022

Life Sciences Review

Drug Discovery and Development

New Innovative Probiotics Reduces Risk of Aspirin-Induced Ulcers

New Innovative Probiotics Reduces Risk of Aspirin-Induced Ulcers

Anders Damholt

PhD Biochemistry, Head of Clinical Development Human Health Innovation & Sara Engel, PhD Human Nutrition, Senior Clinical Development Scientist

Human Health Innovation

Improving Epilepsy Treatment Through Better Formulation

Andy Stewart

Managing Director

Desitin Pharma Ltd

Featured Issue
PreviousNext

Featured Categories

Gynecology and Neurology Medicine Development

Smart Drug Product Formulation Service

#

Navigating Through Drug Discovery and Development

Stefano Biondi, VP of Pre-Clinical Recordati S.p.A [BIT: REC]
#

How Can We Tackle the Health Equity Gap to Innovative Medicines?

Silvy Mardiguian, PhD Market Access Director BeiGene
#

Gynecology And Neurology Medicine Development

A Century of Medical Legacy, Built on Original Therapies

Marco Bertini, R&D and Medical Affairs Manager Laboratori Baldacci S.p.A
#

Smart Drug Product Formulation Service

Turning Formulation into the New R&D Frontier in Pharma

Dr. Mathias Scheer, Founder and CEO Emoviar PharmaCon
Transforming Infertility and Pregnancy Support with Digital Tools

Transforming Infertility and Pregnancy Support with Digital Tools

Kaisla Lahdensuo, Business Director, Specialist Care

Mehiläinen

Accelerating Clinical Trials Through Real-Time Data Analytics and Adaptive Decision-Making

Accelerating Clinical Trials Through Real-Time Data Analytics and Adaptive Decision-Making

An Interview with Katy Moore Pharm. D., R.Ph., President, Clinical Pharmacology Modelling and Simulation; and Alex MacDonald Ph.D., M.Sc., Vice President of Model-Informed Drug Development (MIDD), Allucent

#

Building a More Dependable Route to Medicine Access

Colm Moynihan, President

Evumed Limited

News

Inventus welcomes senior figure from Google as a board adviser

Advancing Nutritional Recovery through Local Therapy

What Medical Device Sponsors Need From European CROs

Clinical-Stage Drug Developers Face Greater Pressure Around Development Planning in Europe

Drug Development for Rare Diseases

Drug Development for Rare Diseases

Fabiana d’Aniello, R&D Portfolio Management Director

Ferrer

The Next Technological Advancement in Resin Development

The Next Technological Advancement in Resin Development

Sofie Stille, Vice President of Technology,

Cytiva

ResoTher Pharma: Improving Cardiovascular Outcomes

Improving Cardiovascular Outcomes

Anders Kronborg, CEO

ALPX: Fast Track The Drug Discovery Journey With ALPX

Fast Track The Drug Discovery Journey With ALPX

Irina Cornaciu-Hoffmann, CEO and Co-Founder

Loading...
#

Unveiling a Game-Changer in Parkinson's Treatment

Prof Dr. Mart Saarma, Senior Partner, Member of Board of Directors,Paavo Pilv, CEO, Member of Management Boar

#

Unlocking Novel First-In-Class Drug Discovery with Collaborative Innovation

Luis Martin, Co-founder and CEO

#

Navigating the Frontiers of Pharmaceutical Advancements

Marina Roussaki, Senior Scientific Project Manager and Sofia Tsatsouli, New Product Development Manager

#

Developing Next-Generation Anti-Thrombotics

Thomas Lines, CEO

Digital Innovation

Digital Innovation

Iris Loew-Friedrich, EVP & Chief Medical Officer, UCB

Innovation Vs Validation in Early Drug Discovery

Innovation Vs Validation in Early Drug Discovery

Carlos Pedraza, PhD. Director of CNS Biology at Alkermes

#

Drug Delivery as a Therapeutic Enabling Technology

Vincent Ling, Senior Director, Takeda

News

European Drug Developers Reassess Manufacturing Partnerships as Generic and Biopharmaceutical Pipelines Grow More Complex

Development Expertise Becomes a Deciding Factor in European Pharmaceutical Outsourcing

European Development Providers Balance Capacity Expansion With Long-Term Scientific Investment

The Next Frontier in European Pharmaceutical Formulations
Transforming Healthcare: The Crucial Role Of Diagnostic Radiology In Influencing Patient Experience And Outcomes

Transforming Healthcare: The Crucial Role Of Diagnostic Radiology In Influencing Patient Experience And Outcomes

Greg Mtunz, General Manager Diagnostic Services, Buckinghamshire Healthcare NHS Trust

Bridging Innovation, Precision and Care

Bridging Innovation, Precision and Care

Puteri Abdul Haris, Consultant in Clinical Oncology, Oxford University Hospitals NHS Foundation Trust

Coping With Ongoing Developments In Oncology

Coping With Ongoing Developments In Oncology

Emma Spellman, Chief Operating Officer, The London Clinic

Strengthening Patient Centricity In Drug Development: The New Evolution In Pharma

Strengthening Patient Centricity In Drug Development: The New Evolution In Pharma

Liselotte Hyveled, Chief Patient Officer, Board member, Novo Nordisk

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://drug-discovery-and-development-europe.lifesciencesrevieweurope.com